ILC accounts for 10–15% of breast cancers and often goes undetected. Learn about its characteristics, treatments, and future ...

Pelago provides personalized treatment for Blue Cross members experiencing opioid or alcohol dependency, offering three ...

The findings, which add to the limited data on the burden of atopic dermatitis on adolescent and pediatric patients, showed ...

No needles, no downtime, no transplants. TED by Alma is the ultrasound-powered, noninvasive hair restoration treatment ...

Clear signs of immune activation: ICT01 at the 10 mg dose provided optimal activation of γ9δ2 T cells and a downstream immune ...

One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months ...

NICE is also looking at the role of Hympavzi in treating severe haemophilia A, where there are other subcutaneous options ...

Realizing their options for medically assisted death are so far limited in New York, a Catskills couple decided to seek it in Oregon.

Media ReleaseCOPENHAGEN, Denmark; May 22, 2025 First presentation of results from Phase 1/2 clinical trial of investigational rinatabart sesutecan (Rina-S®) in patients with recurrent/advanced endomet ...

Learn the signs of pancreatic cancer including unexplained weight loss, distinctive pain patterns, digestive changes, and ...

The sweeping bill is designed to address industry practices that critics say limit patients’ access to care, including mental ...

Margrit Wiesendanger, MD, PhD, discusses how lupus treatment is evolving from traditional therapies to more targeted options like biologics, with promising advances now being explored in clinical ...